PEGylated Apo-A1 (Columbia University/Columbia Technology Ventures)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NamePEGylated Apo-A1 (Columbia University/Columbia Technology Ventures)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApolipoprotein A-I modulators
TargetsApolipoprotein A-I
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesColumbia University
China Registration ClassN/A

Develop Information

Active CompaniesColumbia Technology VenturesColumbia University
Inactive CompaniesN/A
Active IndicationsAtherosclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A